HealthcareServices

Global Molecular Tumor Board Solutions Market 2026–2030: Forecast Insights for Business Planning

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the molecular tumor board solutions market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Molecular Tumor Board Solutions Market?

The molecular tumor board solutions market size has experienced rapid growth in recent years. It is projected to expand from $1.53 billion in 2025 to $1.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.7%. This historic period’s growth can be ascribed to several factors, including the expansion of precision oncology programs, increased availability of genomic sequencing data, the development of multidisciplinary cancer care teams, the rising adoption of clinical decision support software, and improved data sharing across oncology centers.

The molecular tumor board solutions market size is anticipated to experience significant expansion in the coming years. This market is projected to attain a value of $2.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.4%. The projected growth during this period is fueled by several factors, including increasing investments in personalized cancer treatment, a rising demand for molecularly guided therapies, the expansion of cloud deployment in healthcare, growing integration with clinical trial matching platforms, and the increasing adoption of AI-driven oncology analytics. Noteworthy trends expected over the forecast horizon encompass the increasing use of AI-assisted variant interpretation, growing integration of multimodal genomic data, the expansion of cloud-based tumor board platforms, rising adoption of collaborative decision support tools, and an enhanced focus on personalized oncology workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28274&type=smp

Which Drivers Are Supporting The Rise Of The Molecular Tumor Board Solutions Market?

The growing incidence of cancer is anticipated to drive expansion in the molecular tumor board solutions market in the future. Cancer is defined as a collection of illnesses marked by the uncontrolled multiplication and dispersion of irregular cells throughout the body. This rising occurrence of cancer is linked to lifestyle factors including inadequate diet, tobacco use, lack of physical activity, and heavy alcohol intake. In cancer treatment, molecular tumor board solutions assist by offering specialized, cross-disciplinary evaluations of patients’ genomic and clinical information, thereby facilitating customized therapeutic approaches. These solutions improve clinical decision-making through the incorporation of molecular profiling and insights powered by artificial intelligence, leading to better patient results and more precise treatments. As an illustration, the World Health Organization, a global public health agency based in Switzerland, reported in February 2024 a projection of over 35 million new cancer cases by 2050, representing a 77% rise from the estimated 20 million cases in 2022. Consequently, the increasing prevalence of cancer is a key factor propelling the expansion of the molecular tumor board solutions market.

What Segments Are Identified Within The Structure Of The Molecular Tumor Board Solutions Market?

The molecular tumor board solutions market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Clinical Decision Support, Genomic Data Interpretation, Patient Management, Other Applications

4) By End-User: Hospitals, Cancer Centers, Research Institutes, Other End-Users

Subsegments:

1) By Software: Clinical Decision Support, Data Analytics, Reporting And Visualization, Integration Platforms

2) By Services: Consulting, Implementation, Training And Support, Maintenance And Upgrades

Which Trends Are Guiding The Evolution Of The Molecular Tumor Board Solutions Market?

Leading firms in the molecular tumor board solutions market are prioritizing the creation of novel solutions, such as molecular profiling tests, to improve the precision and impact of cancer diagnostics and treatment formulation. These molecular profiling tests are diagnostic tools that examine a tumor’s genetic and molecular traits to inform tailored cancer treatment choices. An example of this is the introduction in April 2025 by Guardant Health Inc., a US-based biotechnology and precision oncology company, of Guardant360 Tissue. This innovative molecular profiling test for tumor tissue incorporates extensive multiomic analysis, covering DNA, RNA, AI-powered PD-L1, and genome-wide methylation data. Driven by the Guardant Infinity smart liquid biopsy platform, this sophisticated test provides a more comprehensive and multifaceted perspective on cancer, facilitating more detailed tumor classification and subtyping. Guardant360 Tissue produces results in less than two weeks, qualifies for Medicare coverage for eligible patients, and strives to advance precision oncology by supplying more profound insights to direct treatment decisions, including for therapies such as poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapies.

Which Key Players Are Driving Competition In The Molecular Tumor Board Solutions Market?

Major companies operating in the molecular tumor board solutions market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Illumina Inc., Novogene Co. Ltd., QIAGEN N.V., Myriad Genetics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Mayo Clinic Laboratories, Sectra AB, GenomOncology LLC, MedGenome Labs Ltd., Burning Rock Biotech Limited, NantHealth Inc., SOPHiA GENETICS SA, Variantyx Inc., Baylor Genetics, Molecular Health GmbH, PierianDx Inc., Oncompass Medicine, CureMatch Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/molecular-tumor-board-solutions-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Molecular Tumor Board Solutions Market?

North America was the largest region in the molecular tumor board solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular tumor board solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Molecular Tumor Board Solutions Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28274&type=smp

Browse Through More Reports Similar to the Global Molecular Tumor Board Solutions Market 2026, By The Business Research Company

Solid Tumor Cancer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Anti Cancer Mabs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-cancer-mabs-global-market-report

Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795